Press Releases about Gilead Sciences
Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030
February 09, 2023
Via SBWire
![]()
Europe Liver Cancer Therapeutics Market Is at the Cusp of Crossing CAGR of 8.95% N 2023-2030
February 08, 2023
Via SBWire
Topics
Death
Exposures
Death
![]() ![]() ![]() ![]() Via Business Wire
![]() Via Business Wire
![]() Via Business Wire
![]() Via Business Wire
![]() ![]()
Gilead Sciences to Present at Upcoming Investor Conferences
January 27, 2023
Via Business Wire
![]() ![]() ![]() ![]() Via Business Wire
![]() ![]()
Gilead Sciences to Present at Upcoming Investor Conference
December 23, 2022
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
Gilead Sciences Again Named to Dow Jones Sustainability World Index
December 12, 2022
Via Business Wire
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|